Weekly news updates are currently posted on the Internet site and sent out via e-blast to provide up-to-date information on what has been covered in the news regarding lung cancer in the previous week. Topics include all stories related to lung cancer as well as personal stories and events.
Week ending October 19, 2014
“ASCO has endorsed the CAP/IASLC/AMP guideline on molecular testing for patients with lung cancer, which recommends EGFR and ALK testing for all patients with lung adenocarcinoma or mixed histology with an adenocarcinoma component.”
Cicero (WSYR-TV) – “This week, researchers revealed lung cancer can lie dormant for more than 20 years before becoming aggressive.”
“The Princess Margaret Cancer Centre has marked an important step toward its goal of becoming a world leader in personalized cancer medicine by announcing the largest-ever expansion of research space in the hospital’s history.”
“Removal of the entire lobe of lung may offer patients with early-stage lung cancer better overall survival when compared with a partial resection, and stereotactic ablative radiotherapy (SABR) may offer the same survival benefit as a lobectomy for some patients, according to a study from The University of Texas MD Anderson Cancer Center.”
“As with any cancer diagnosis, the first thought you may have after you’re told that you have lung cancer is “get it out of me,” and this instinct is quite accurate when considering chances for cure. According to the American Lung Association, lung cancer continues to present the leading cause of cancer deaths in the nation, with a death toll greater than the three next most common types of cancer combined.”